• Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis🔍
• NCT03104400🔍
• 56|week data from the phase 3 SELECT|PsA 1 study🔍
• Results from SELECT|PsA 1🔍
• 3|YEAR RESULTS FROM THE PHASE 3 SELECT|PsA 1 STUDY🔍
• a post hoc analysis of SELECT|PsA 1 and 2 trials🔍
• Efficacy and safety of upadacitinib in patients with active psoriatic ...🔍
• Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis🔍

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

We conducted SELECT-PsA 1, a double-blind, phase 3 trial comparing upadacitinib with placebo and with adalimumab as an active comparator in ...

NCT03104400 - ClinicalTrials.gov

56-week data from the phase 3 SELECT-PsA 1 study - PubMed

Upadacitinib 15 mg and 30 mg were superior to placebo and non-inferior to adalimumab in ≥20% improvement in American College of Rheumatology (ACR) criteria at ...

Results from SELECT-PsA 1 - PMC

The SELECT-PsA 1 RCT compared upadacitinib 15 and 30 mg with placebo and adalimumab as an active comparator in non-bDMARD-IR patients with PsA [14].

3-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY

Efficacy of UPA in nbDMARD-IR pts with PsA was maintained through 3 years of treatment. No new safety signals were identified.

56-week data from the phase 3 SELECT-PsA 1 study | RMD Open

Efficacy across various domains of PsA were maintained with upadacitinib 15 mg and 30 mg through week 56 with no new safety signals observed.

a post hoc analysis of SELECT-PsA 1 and 2 trials | Rheumatology

Conclusion. This post hoc analysis expands on the primary analyses of the SELECT-PsA 1 and 2 studies, demonstrating that upadacitinib is ...

Efficacy and safety of upadacitinib in patients with active psoriatic ...

... psoriatic arthritis (PsA) patients with axial involvement. Post-hoc analysis of SELECT-PsA 1 and SELECT-PsA 2 in patients randomized to

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis

In the phase 3 SELECT-PsA 1 study, patients with active psoriatic arthritis (PsA) and an inadequate response or intolerance to ≥ 1 non ...

POETYK PsA-1 - Deucravacitinib in naive patients with PsA (IM011 ...

PsA is a type of arthritis that affects some people with the skin condition, psoriasis. This study will test an investigational study drug, called ...

Psoriatic Arthritis Treatment | RINVOQ® (upadacitinib)

SELECT-PsA 1 Study Design Intro:1 24-week, double‑blind, placebo and active comparator-controlled study of 1705 adult patients with moderately to severely ...

AbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ®) in ...

Post-hoc analyses of the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 trials show people with active psoriatic arthritis (PsA) demonstrated greater ...

SELECT-PsA 1 and SELECT-PsA 2 Extended Trial Results Show ...

The long-term data from these two trials, SELECT-PsA 1 and SELECT-PsA 2 demonstrated a catch up phenomenon in which the better tolerated lower ...

HUMIRA® (adalimumab) for Psoriatic Arthritis (PsA)

Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in active PsA1. ADEPT.

SELECT-PsA 1 and SELECT-PsA 2 in Psoriatic Arthritis - HCPLive

These data are from the SELECT-PsA 1 and 2 trials using a drug known as upadacitinib, a relatively specific JAK1 inhibitor, in the treatment of psoriatic ...

RINVOQ® (upadacitinib) for active Psoriatic Arthritis (PsA)

Serious Infections, Cancer and Immune System Problems, and Blood Clots. · Increased risk of death in people age 50+ with at least 1 heart disease risk factor.

Police Service Area 1 - NYPD - NYC.gov

PSA 1's Red Hook satellite is located at 80 Dwight Street, Red Hook, Brooklyn, NY, 11224. The satellite serves the New York City Housing Authority developments ...

PSA Plano > Home

PSA was founded as a non-profit organization in December 1970 when the local individual sports leagues incorporated to form one administrative youth sports ...

PSA1 | Professional Studio Boom Arm - RØDE

... Select Sennheiser Devices. MiCon-2 Connector ... Find out more. NT1 & AI-1 Complete Studio Kit. Learn More ...

Select Agents and Toxins List

... select toxin may be excluded from the requirements of the Select Agent Regulations. ... Xanthomonas oryzae. [1] Denotes Tier 1 Agent. [2] C = Cysteine residues ...